ArticleBMJ nutrition, prevention & health2025
Associations of serum choline, betaine and trimethylamine N-oxide with gestational diabetes mellitus among Chinese pregnant women.
Article in BMJ nutrition, prevention & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Mechanistic studies indicated beneficial effects of choline and betaine on glucose homeostasis during pregnancy. However, limited human studies explored the associations of biomarkers of choline and its related metabolites with gestational diabetes mellitus (GDM) and results remained inconsistent. This study aimed to explore associations of serum choline, betaine and trimethylamine N-oxide (TMAO) with GDM odds among Han Chinese women. Research design and methods: Pregnant women with singleton gestation were enrolled during GDM screening between 24 and 28 weeks of gestation at the Seventh People's Hospital in Shanghai, China. Women with GDM cases (n=173) and non-GDM controls (healthy women without pregnancy-related complications, n=158) were enrolled. Serum metabolites were measured by ultra-high performance liquid chromatography-multiple reaction monitoring-tandem mass spectrometry method. Multivariable logistic regression analyses were used to estimate ORs and their 95% CIs for the associations of these three metabolites with likelihood of GDM. Results: Compared with the lowest tertile of serum choline and betaine, women in the highest tertile had a multivariate-adjusted OR (95% CI) for GDM odds of 0.55 (0.30, 1.00) and 0.55 (0.30, 1.00), respectively. No significant association was found between serum TMAO and GDM odds. In addition, the stratified analysis results showed that among women with abnormal weight gain during pregnancy, there was a significant inverse association between serum betaine and GDM odds [OR (95% CI), 0.26 (0.13, 0.57)]. Conclusion: Serum choline and betaine, but not TMAO, tend to be inversely associated with GDM odds among Han Chinese women with singleton gestation. Especially among those women with abnormal weight gain during pregnancy, higher serum betaine was associated with lower GDM likelihood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.